Joan Padrosa

498 total citations
16 papers, 86 citations indexed

About

Joan Padrosa is a scholar working on Oncology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joan Padrosa has authored 16 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joan Padrosa's work include Cancer Immunotherapy and Biomarkers (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Patient Dignity and Privacy (3 papers). Joan Padrosa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Patient Dignity and Privacy (3 papers). Joan Padrosa collaborates with scholars based in Spain, Argentina and United States. Joan Padrosa's co-authors include Javier Ros, José C. Milisenda, Josep M. Grau, Sergio Prieto‐González, Ernesto Trallero‐Araguás, Natalia Castrejón de Anta, Ana Matas-García, Manel Solé, Albert Selva-O’Callaghan and Javier Marco‐Hernández and has published in prestigious journals such as Lara D. Veeken, Cancers and Journal of Thoracic Oncology.

In The Last Decade

Joan Padrosa

14 papers receiving 85 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Padrosa Spain 5 45 30 12 12 11 16 86
Emilia Roy‐Vallejo Spain 7 28 0.6× 35 1.2× 15 1.3× 14 1.2× 13 1.2× 13 115
Antoine Lafarge France 7 34 0.8× 28 0.9× 16 1.3× 9 0.8× 2 0.2× 23 129
Jason Yang United States 6 31 0.7× 15 0.5× 9 0.8× 9 0.8× 17 1.5× 17 130
Alban Villate France 6 20 0.4× 23 0.8× 6 0.5× 7 0.6× 7 0.6× 18 83
Carolin Jakob Germany 6 27 0.6× 15 0.5× 7 0.6× 18 1.5× 9 0.8× 15 87
Karine Augeul-Meunier France 7 46 1.0× 13 0.4× 23 1.9× 7 0.6× 7 0.6× 13 108
Mihaiela L. Blaga Romania 4 15 0.3× 20 0.7× 5 0.4× 15 1.3× 13 1.2× 5 86
Maria Laura Dessanti Italy 6 32 0.7× 41 1.4× 3 0.3× 8 0.7× 4 0.4× 9 95
Corina Moldovan Romania 5 14 0.3× 32 1.1× 18 1.5× 12 1.0× 29 2.6× 13 130
Anastasios Vagionas Greece 8 43 1.0× 14 0.5× 19 1.6× 9 0.8× 21 1.9× 27 173

Countries citing papers authored by Joan Padrosa

Since Specialization
Citations

This map shows the geographic impact of Joan Padrosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Padrosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Padrosa more than expected).

Fields of papers citing papers by Joan Padrosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Padrosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Padrosa. The network helps show where Joan Padrosa may publish in the future.

Co-authorship network of co-authors of Joan Padrosa

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Padrosa. A scholar is included among the top collaborators of Joan Padrosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Padrosa. Joan Padrosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tobías, Ester, Francesc Josep García‐García, Mariona Guitart‐Mampel, et al.. (2025). Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis. Acta Neuropathologica Communications. 13(1). 38–38. 1 indexed citations
2.
Reyes, Roxana, Gemma Carrera, Pedro Castro, et al.. (2025). Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence. Current Oncology. 32(10). 568–568.
3.
4.
Herreros, Marta García de, Joan Padrosa, Carme Font, et al.. (2024). Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment. Diagnostics. 14(7). 730–730. 3 indexed citations
5.
Herreros, Marta García de, Natàlia Jiménez, Leonardo Rodríguez‐Carunchio, et al.. (2024). Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors. European Urology Open Science. 70. 86–90. 3 indexed citations
6.
7.
Tobías, Ester, Francesc Josep García‐García, Mariona Guitart‐Mampel, et al.. (2023). Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis. Antioxidants. 12(8). 1639–1639. 2 indexed citations
8.
Xipell, Marc, Gastón Piñeiro, Miguel Blasco, et al.. (2022). Differentiating Acute Interstitial Nephritis From Immune Checkpoint Inhibitors From Other Causes. Kidney International Reports. 8(3). 672–675. 3 indexed citations
9.
10.
Auclin, Édouard, Roxana Reyes, Cristina Teixidó, et al.. (2021). P09.15 Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19. Journal of Thoracic Oncology. 16(3). S294–S295. 1 indexed citations
11.
Martínez-Vila, Clara, Elia Seguí, Joan Padrosa, et al.. (2021). Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma. Journal of Immunotherapy. 44(5). 204–207. 3 indexed citations
12.
Tuca, Albert, et al.. (2020). Prevalence of ethical dilemmas in advanced cancer patients (secondary analysis of the PALCOM study). Supportive Care in Cancer. 29(7). 3667–3675. 9 indexed citations
13.
Moreno, Pedro, et al.. (2020). Statin use and myopathy. Not always guilty. Lara D. Veeken. 59(12). 3853–3857. 1 indexed citations
14.
Matas-García, Ana, José C. Milisenda, Albert Selva-O’Callaghan, et al.. (2019). Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern. Autoimmunity Reviews. 19(2). 102455–102455. 40 indexed citations
15.
Padrosa, Joan, et al.. (2019). Comparison of the Quick Sepsis-related Organ Dysfunction score and severity levels assigned with the Andorran Triage Model in an urban tertiary care hospital emergency department.. PubMed. 30(6). 400–404. 5 indexed citations
16.
Padrosa, Joan, et al.. (2018). COMPARACIÓN DEL INDICADOR ‘QUICK SOFA’ RESPECTO A LOS NIVELES ASIGNADOS POR EL ‘MODELO ANDORRANO DE TRIAJE’ EN LA CLASIFICACIÓN DE LOS PACIENTES QUE ACUDEN A UN SERVICIO DE URGENCIAS DE UN HOSPITAL URBANO DE TERCER NIVEL.. Emergencias. 30(6). 400–404. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilia Roy‐Vallejo Breakdown of academic impact, for papers by Antoine Lafarge Breakdown of academic impact, for papers by Jason Yang Breakdown of academic impact, for papers by Alban Villate Breakdown of academic impact, for papers by Carolin Jakob Breakdown of academic impact, for papers by Karine Augeul-Meunier Breakdown of academic impact, for papers by Mihaiela L. Blaga Breakdown of academic impact, for papers by Maria Laura Dessanti Breakdown of academic impact, for papers by Corina Moldovan Breakdown of academic impact, for papers by Anastasios Vagionas
Rankless by CCL
2026